Jefferies on Protagonist Therapeutics (PTGX): 'well-funded for multiple high value oral peptide pipeline'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. MMED
6. CRDO
7. AAPL
8. SPY
9. NIO
10. DH

Go back to Jefferies on Protagonist Therapeutics (PTGX): 'well-funded for multiple high value oral peptide pipeline'
(NASDAQ: PTGX) Delayed: 148.82 +2.33 (1.59%)
Previous Close $146.49    52 Week High $24.52 
Open $148.00    52 Week Low $10.02 
Day High $149.28    P/E N/A 
Day Low $146.98    EPS $0.00 
Volume 26,942